Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Eugia Pharma Specialities Limited | Sangareddy, India | Makes it, tests it and packages it | Serious problems, FDA actionFeb 6, 2026 · 7 inspections, 2 with FDA action |
Recalls
- May 22, 2024 · Class III · Eugia US LLC
Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
Lots: Lot #: 3EF22003, Exp 6/30/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Eptifibatide: every company that makes it
- Form
- injection, intravenous
- Strength
- 75 mg per 100 mL
- Approval
- ANDA ANDA206127
- On the market since
- Dec 8, 2015
- Package NDCs
55150-218-99- Official label
- DailyMed (National Library of Medicine), updated Jan 4, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?